{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T14:41:41Z","timestamp":1774363301972,"version":"3.50.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,8,31]],"date-time":"2013-08-31T00:00:00Z","timestamp":1377907200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s40257-013-0041-9","type":"journal-article","created":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T09:34:13Z","timestamp":1377855253000},"page":"351-358","source":"Crossref","is-referenced-by-count":12,"title":["The Management of Acne Vulgaris in Pregnancy"],"prefix":"10.1007","volume":"14","author":[{"given":"Fiona M.","family":"Meredith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony D.","family":"Ormerod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,31]]},"reference":[{"key":"41_CR1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1046\/j.1365-2133.2001.04346.x","volume":"145","author":"A Smithard","year":"2001","unstructured":"Smithard A, Glazebrook C, Williams HC. Acne prevalence, knowledge about acne and psychological morbidity in mid-adolescence: a community-based study. Br J Dermatol. 2001;145:274\u20139.","journal-title":"Br J Dermatol"},{"key":"41_CR2","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/bjd.12149","volume":"168","author":"K Bhate","year":"2013","unstructured":"Bhate K, Williams HC. Epidemiology of acne vulgaris. Br J Dermatol. 2013;168:474\u201385.","journal-title":"Br J Dermatol"},{"issue":"5","key":"41_CR3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00128071-200607050-00002","volume":"7","author":"C Williams","year":"2006","unstructured":"Williams C, Layton AM. Persistent acne in women: implications for the patient and for therapy. Am J Clin Dermatol. 2006;7(5):281\u201390.","journal-title":"Am J Clin Dermatol"},{"key":"41_CR4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1046\/j.1365-2133.2001.04290.x","volume":"145","author":"T Shafer","year":"2001","unstructured":"Shafer T, Nienhaus A, Vieluf D, et al. Epidemiology of acne in the general population: the risk of smoking. Br J Dermatol. 2001;145:100\u20134.","journal-title":"Br J Dermatol"},{"key":"41_CR5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2133.1971.tb07195.x","volume":"85","author":"JL Burton","year":"1971","unstructured":"Burton JL, Cunliffe WJ, Stafford I, et al. The prevalence of acne vulgaris in adolescence. Br J Dermatol. 1971;85:119\u201326.","journal-title":"Br J Dermatol"},{"key":"41_CR6","unstructured":"US Food and Drug Administration. List of pregnancy exposure registries [online]. http:\/\/www.fda.gov\/scienceresearch\/specialtopics\/womenshealthresearch\/ucm134848.htm (Accessed 12 Dec 2012)."},{"key":"41_CR7","unstructured":"FDA Consumer Health Information. Pregnant women to benefit from better information [online]. http:\/\/www.fda.gov\/downloads\/ForConsumers\/ConsumerUpdates\/UCM143746.pdf (Accessed 12 Dec 2012)."},{"key":"41_CR8","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jaad.2006.08.048","volume":"56","author":"JS Strauss","year":"2007","unstructured":"Strauss JS, Krowchuk DP, Leyden JJ, et al. Guidelines of care for acne vulgaris management. J Am Acad Dermatol. 2007;56:651\u201363.","journal-title":"J Am Acad Dermatol"},{"key":"41_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.2011.04374.x","volume":"26","author":"A Nast","year":"2012","unstructured":"Nast A, Dr\u00e9no B, Bettoli V, et al. European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol. 2012;26:1\u201329.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"41_CR10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0738-081X(96)00108-3","volume":"15","author":"SV Elling","year":"1997","unstructured":"Elling SV, Powell FC. Physiological changes in the skin during pregnancy. Clin Dermatol. 1997;15:35\u201343.","journal-title":"Clin Dermatol"},{"key":"41_CR11","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/bmj.2.5712.769","volume":"2","author":"JL Burton","year":"1970","unstructured":"Burton JL, Cunliffe WJ, Millar DG, Shuster S. Effect of pregnancy on sebum excretion. BMJ. 1970;2:769\u201371.","journal-title":"BMJ"},{"key":"41_CR12","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1046\/j.1365-4362.1998.00281.x","volume":"37","author":"F Muzaffar","year":"1998","unstructured":"Muzaffar F, Hussain I, Haroon TS. Physiologic skin changes during pregnancy: a study of 140 cases. Int J Dermatol. 1998;37:429\u201331.","journal-title":"Int J Dermatol"},{"key":"41_CR13","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1053\/beog.2001.0231","volume":"15","author":"M Dawes","year":"2001","unstructured":"Dawes M, Chowienczyk PJ. Drugs in pregnancy: pharmacokinetics in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2001;15:819\u201326.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"41_CR14","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2165\/00003088-199733050-00002","volume":"33","author":"R Loebstein","year":"1997","unstructured":"Loebstein R, Lalkin A, Koren G. Pharmacokinetic changes during pregnancy and their clinical relevance. Clin Pharmacokinet. 1997;33:328\u201343.","journal-title":"Clin Pharmacokinet"},{"key":"41_CR15","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1345\/aph.1A034","volume":"35","author":"LA Boothby","year":"2001","unstructured":"Boothby LA, Doering PL. FDA labeling system for drugs in pregnancy. Ann Pharmacother. 2001;35:1485\u20139.","journal-title":"Ann Pharmacother"},{"key":"41_CR16","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/bdra.20389","volume":"79","author":"Public Affairs Committee of the Teratology Society","year":"2007","unstructured":"Public Affairs Committee of the Teratology Society. Teratology Public Affairs Committee position paper: pregnancy labeling for prescription drugs: ten years later. Birth Defects Res Part A Clin Mol Teratol. 2007;79:627\u201330.","journal-title":"Birth Defects Res Part A Clin Mol Teratol"},{"issue":"3","key":"41_CR17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2165\/00002018-200023030-00006","volume":"23","author":"A Addis","year":"2000","unstructured":"Addis A, Sharabi S, Bonati M. Risk classification systems for drug use during pregnancy: are they a reliable source of information? Drug Saf. 2000;23(3):245\u201353.","journal-title":"Drug Saf"},{"key":"41_CR18","unstructured":"US Food and Drug administration. Pregnancy and lactation labeling [online]. http:\/\/www.fda.gov\/Drugs\/DevelopmentApprovalProcess\/DevelopmentResources\/Labeling\/ucm093307.htm (Accessed 12 Dec 2012)."},{"key":"41_CR19","unstructured":"MIMS USA drug information system [online]: http:\/\/www.mims.com\/USA\/Viewer\/Html\/PregDef.htm (Accessed 12 Dec 2012)."},{"issue":"5 Suppl.","key":"41_CR20","first-page":"5","volume":"82","author":"E Tanghetti","year":"2008","unstructured":"Tanghetti E. The evolution of benzoyl peroxide therapy. Cutis. 2008;82(5 Suppl.):5\u201311.","journal-title":"Cutis"},{"key":"41_CR21","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0190-9622(83)70209-4","volume":"9","author":"D Yeung","year":"1983","unstructured":"Yeung D, Nacht S, Bucks D, Maibach HI. Benzoyl peroxide: percutaneous penetration and metabolic disposition. II. Effect of concentration. J Am Acad Dermatol. 1983;9:920\u20134.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"41_CR22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0190-9622(81)70004-5","volume":"4","author":"S Nacht","year":"1981","unstructured":"Nacht S, Yeung D, Beasley JN, et al. Benzoyl peroxide: percutaneous penetration and metabolic disposition. J Am Acad Dermatol. 1981;4(1):31\u20137.","journal-title":"J Am Acad Dermatol"},{"key":"41_CR23","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0140-6736(92)90854-V","volume":"339","author":"G Camera","year":"1992","unstructured":"Camera G, Pregliasco P. Ear malformation in baby born to mother using tretinoin cream. Lancet. 1992;339:687.","journal-title":"Lancet"},{"key":"41_CR24","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/0140-6736(93)90868-H","volume":"341","author":"AH Lipson","year":"1993","unstructured":"Lipson AH, Collins C, Webster W. Multiple congenital defects associated with maternal use of topical tretinoin. Lancet. 1993;341:1352\u20133.","journal-title":"Lancet"},{"key":"41_CR25","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0387-7604(00)00104-2","volume":"22","author":"D Selcen","year":"2000","unstructured":"Selcen D, Seidman S, Nigro MA. Otocerebral anomalies associated with topical tretinoin use. Brain Dev. 2000;22:218\u201320.","journal-title":"Brain Dev"},{"key":"41_CR26","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1345\/aph.17138","volume":"32","author":"C Navarre-Belhassen","year":"1998","unstructured":"Navarre-Belhassen C, Blanchet P, Hillaire-Buys D, et al. Multiple congenital malformations associated with topical tretinoin. Ann Pharmacother. 1998;32:505\u20136.","journal-title":"Ann Pharmacother"},{"key":"41_CR27","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(05)63390-9","volume":"350","author":"E Autret","year":"1997","unstructured":"Autret E, Berjot M, Jonville-B\u00e9ra A-P, et al. Anophthalmia and agenesis of optic chiasma associated with adapalene gel in early pregnancy. Lancet. 1997;350:339.","journal-title":"Lancet"},{"key":"41_CR28","unstructured":"Organisation of Teratology Information specialists. Tretinoin (Retin-A\u00ae) and pregnancy [online]. http:\/\/www.otispregnancy.org\/files\/tretinoin.pdf (Accessed 12 Dec 2012)."},{"key":"41_CR29","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/0140-6736(93)91004-6","volume":"341","author":"SS Jick","year":"1993","unstructured":"Jick SS, Terris BZ, Jick H. First trimester topical tretinoin and congenital disorders. Lancet. 1993;341:1181\u20132.","journal-title":"Lancet"},{"key":"41_CR30","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1177\/0091270011429566","volume":"52","author":"P Panchaud","year":"2012","unstructured":"Panchaud P, Csajka C, Merlob P, et al. Pregnancy outcome following exposure to topical retinoids: a multicentre prospective study. J Clin Pharmacol. 2012;52:1844\u201351.","journal-title":"J Clin Pharmacol"},{"key":"41_CR31","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1111\/j.1468-3083.1998.tb00902.x","volume":"11 Suppl. 1","author":"EJ Hoogdalem Van","year":"1998","unstructured":"Van Hoogdalem EJ. Transdermal absorption of topical anti-acne agents in man; review of clinical pharmacokinetic data. J Eur Acad Dermatol Venereol. 1998;11 Suppl. 1:S13\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"41_CR32","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2165\/00128071-200304070-00004","volume":"4","author":"A Akhavan","year":"2003","unstructured":"Akhavan A, Bershad S. Topical acne drugs: review of clinical properties, systemic exposure and safety. Am J Clin Dermatol. 2003;4:473\u201392.","journal-title":"Am J Clin Dermatol"},{"key":"41_CR33","volume-title":"British National Formulary","author":"Joint Formulary Committee","year":"2012","unstructured":"Joint Formulary Committee. British National Formulary. 64th ed. London: BMJ Group and Pharmaceutical Press; 2012.","edition":"64"},{"key":"41_CR34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2165\/00128071-200405010-00009","volume":"5","author":"JE Frampton","year":"2004","unstructured":"Frampton JE, Wagstaff AJ. Azelaic acid 15% gel in treatment of papulopustular rosacea. Am J Clin Dermatol. 2004;5:57\u201364.","journal-title":"Am J Clin Dermatol"},{"key":"41_CR35","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1600-0625.1992.tb00185.x","volume":"1","author":"U T\u00e4uber","year":"1992","unstructured":"T\u00e4uber U, Weiss C, Matthes H. Percutaneous absorption of azelaic acid in humans. Exp Dermatol. 1992;1:176\u20139.","journal-title":"Exp Dermatol"},{"key":"41_CR36","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJM199804163381607","volume":"338","author":"G Koren","year":"1998","unstructured":"Koren G, Pastuszak A, Ito S. Drugs in pregnancy. N Engl J Med. 1998;338:1128\u201337.","journal-title":"N Engl J Med"},{"key":"41_CR37","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/1523-1747.ep12259184","volume":"54","author":"RJ Feldmann","year":"1970","unstructured":"Feldmann RJ, Maibach HI. Absorption of organic compounds through the skin in man. J Invest Dermatol. 1970;54:399\u2013404.","journal-title":"J Invest Dermatol"},{"key":"41_CR38","first-page":"391","volume":"14","author":"B Dreno","year":"2004","unstructured":"Dreno B, Bettoli V, Ochsendorf F, et al. European recommendations on the use of oral antibiotics for acne. Eur J Dermatol. 2004;14:391\u20139.","journal-title":"Eur J Dermatol"},{"key":"41_CR39","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1365-2133.1992.tb00104.x","volume":"126","author":"KS Harkaway","year":"1992","unstructured":"Harkaway KS, McGinley KJ, Foglia AN, et al. Antibiotic resistance patterns in coagulase-negative staphylococci after treatment with topical erythromycin, benzoyl peroxide, and combination therapy. Br J Dermatol. 1992;126:586\u201390.","journal-title":"Br J Dermatol"},{"key":"41_CR40","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJM200011303432204","volume":"343","author":"S Hernandez","year":"2000","unstructured":"Hernandez S, Werler MM, Walker AM, et al. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med. 2000;343:1608\u201314.","journal-title":"N Engl J Med"},{"key":"41_CR41","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1365-4362.2002.01464.x","volume":"41","author":"EK Hale","year":"2002","unstructured":"Hale EK, Pomeranz MK. Dermatological agents during pregnancy and lactation: an update and clinical review. Int J Dermatol. 2002;41:197\u2013203.","journal-title":"Int J Dermatol"},{"key":"41_CR42","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2133.1972.tb05095.x","volume":"87","author":"WJ Cunliffe","year":"1972","unstructured":"Cunliffe WJ, C\u2019otterill JA, Williamson B. The effect of clindamycin in acne: a clinical and laboratory investigation. Br J Dermatol. 1972;87:37\u201341.","journal-title":"Br J Dermatol"},{"key":"41_CR43","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2133.1976.tb04389.x","volume":"94","author":"SG Tan","year":"1976","unstructured":"Tan SG, Cunliffe WJ. The unwanted effects of clindamycin in acne. Br J Dermatol. 1976;94:313\u20135.","journal-title":"Br J Dermatol"},{"issue":"Suppl. 1","key":"41_CR44","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1086\/521859","volume":"46","author":"RC Owens","year":"2008","unstructured":"Owens RC, Donskey CJ, Gayens RP, et al. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis. 2008;46(Suppl. 1):S19\u201331.","journal-title":"Clin Infect Dis"},{"key":"41_CR45","volume-title":"Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk","author":"GG Briggs","year":"2008","unstructured":"Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2008.","edition":"8"},{"key":"41_CR46","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1365-2125.2012.04286.x","volume":"74","author":"M Rom\u00f8ren","year":"2012","unstructured":"Rom\u00f8ren M, Lindb\u00e6k M, Nordeng H. Pregnancy outcome after gestational exposure to erythromycin: a population-based register study from Norway. Br J Clin Pharmacol. 2012;74:1053\u201362.","journal-title":"Br J Clin Pharmacol"},{"issue":"5 Suppl.","key":"41_CR47","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaad.2009.01.019","volume":"60","author":"D Thiboutot","year":"2009","unstructured":"Thiboutot D, Gollnick H, Bettoli V, et al. New insights into the management of acne: an update from the Global Alliance to improve outcomes in acne group. J Am Acad Dermatol. 2009;60(5 Suppl.):S1\u201350.","journal-title":"J Am Acad Dermatol"},{"key":"41_CR48","volume-title":"Martindale: the complete drug reference","author":"SC Sweetman","year":"2005","unstructured":"Sweetman SC, et al. Martindale: the complete drug reference. 34th ed. London: Pharmaceutical Press; 2005.","edition":"34"},{"key":"41_CR49","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2230.2005.01769.x","volume":"30","author":"S Kus","year":"2004","unstructured":"Kus S, Yucelten D, Aytug A. Comparison of efficacy of azithromycin vs. doxycycline in the treatment of acne vulgaris. Clin Exp Dermatol. 2004;30:215\u201320.","journal-title":"Clin Exp Dermatol"},{"key":"41_CR50","unstructured":"UK Medicines and Healthcare products Regulatory Agency (MHRA) azithromycin UKPAR (UK Public Assessment Reports for medicines). http:\/\/www.mhra.gov.uk\/home\/groups\/pl-a\/documents\/websiteresources\/con023376.pdf (Accessed 4 July 2013)."},{"key":"41_CR51","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2133.1984.tb04045.x","volume":"111","author":"A Goodfellow","year":"1984","unstructured":"Goodfellow A, Alaghband-Zadeh J, Carter G, et al. Oral spironolactone improves acne vulgaris and reduces sebum excretion. Br J Dermatol. 1984;111:209\u201314.","journal-title":"Br J Dermatol"},{"key":"41_CR52","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2133.1986.tb05722.x","volume":"115","author":"MF Muhlemann","year":"1986","unstructured":"Muhlemann MF, Carter GD, Cream JJ, Wise P. Oral spironolactone: an effective treatment for acne vulgaris in women. Br J Dermatol. 1986;115:227\u201332.","journal-title":"Br J Dermatol"},{"key":"41_CR53","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1095\/biolreprod32.5.1051","volume":"32","author":"V Jaussan","year":"1985","unstructured":"Jaussan V, Lemarchand-Beraud T, Gomez F. Modifications of the gonadal function in the adult rat after fetal exposure to spironolactone. Biol Reprod. 1985;32:1051\u201361.","journal-title":"Biol Reprod"},{"key":"41_CR54","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1365-2133.2010.09836.x","volume":"162","author":"MJ Goodfield","year":"2010","unstructured":"Goodfield MJ, Cox NH, Bowser A, et al. Advice on the safe introduction and continued use of isotretinoin in acne in the U.K.: 2010. Br J Dermatol. 2010;162:1172\u20139.","journal-title":"Br J Dermatol"},{"key":"41_CR55","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1056\/NEJM198510033131401","volume":"313","author":"EJ Lammer","year":"1985","unstructured":"Lammer EJ, Chen DT, Hoar RM, et al. Retinoic acid embryopathy. N Engl J Med. 1985;313:837\u201341.","journal-title":"N Engl J Med"},{"issue":"1","key":"41_CR56","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.annder.2007.07.001","volume":"135","author":"B Dreno","year":"2008","unstructured":"Dreno B, Blouin E. Acne, pregnant women and zinc salts: a literature review. Ann Dermatol Venereol. 2008;135(1):27\u201333.","journal-title":"Ann Dermatol Venereol"},{"key":"41_CR57","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/11588900-000000000-00000","volume":"12","author":"A Du-Thanh","year":"2011","unstructured":"Du-Thanh A, Klugr N, Bensalleh H, Guillot B. Drug-induced acneiform eruption. Am J Clin Dermatol. 2011;12:233\u201345.","journal-title":"Am J Clin Dermatol"},{"key":"41_CR58","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1365-2133.1999.02982.x","volume":"141","author":"DC Seukeran","year":"1999","unstructured":"Seukeran DC, Cunliffe WJ. The treatment of acne fulminans: a review of 25 cases. Br J Dermatol. 1999;141:307\u20139.","journal-title":"Br J Dermatol"},{"key":"41_CR59","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.reprotox.2003.10.007","volume":"18","author":"C Gur","year":"2004","unstructured":"Gur C, Diav-Citrin O, Shechtman S, et al. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study. Reprod Toxicol. 2004;18:93\u2013101.","journal-title":"Reprod Toxicol"},{"key":"41_CR60","unstructured":"Committee on safety of medicines\/medicines control agency. Systemic corticosteroids in pregnancy and lactation. Curr Probl. 1998;24:9. http:\/\/www.mhra.gov.uk\/home\/groups\/pl-p\/documents\/websiteresources\/con2023392.pdf (Accessed 28 June 2013)."},{"key":"41_CR61","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1529-8019.2005.05024.x","volume":"18","author":"EV Ross","year":"2005","unstructured":"Ross EV. Optical treatments for acne. Dermatol Ther. 2005;18:253\u201366.","journal-title":"Dermatol Ther"},{"key":"41_CR62","doi-asserted-by":"crossref","unstructured":"Car J, Car M, Hamilton F, et al. Light therapies for acne (intervention protocol). Cochrane Database Syst Rev. 2009;(3):CD007917.","DOI":"10.1002\/14651858.CD007917"},{"key":"41_CR63","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jaad.2009.09.057","volume":"63","author":"FH Sakamoto","year":"2010","unstructured":"Sakamoto FH, Torezan L, Anderson R. Photodynamic therapy for acne vulgaris: a critical review from basics to clinical practice: part II. Understanding parameters for acne treatment with photodynamic therapy. J Am Acad Dermatol. 2010;63:195\u2013211.","journal-title":"J Am Acad Dermatol"},{"key":"41_CR64","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1001\/archdermatol.2011.96","volume":"147","author":"JA Zeichner","year":"2011","unstructured":"Zeichner JA. Narrowband UV-B phototherapy for the treatment of acne vulgaris during pregnancy. Arch Dermatol. 2011;147:537\u20139.","journal-title":"Arch Dermatol"},{"key":"41_CR65","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1046\/j.1365-2133.2000.03531.x","volume":"142","author":"WJ Cunliffe","year":"2000","unstructured":"Cunliffe WJ, Holland DB, Clark SM, Stables GI. Comedogenesis: some new aetiological, clinical and therapeutic strategies. Br J Dermatol. 2000;142:1084\u201391.","journal-title":"Br J Dermatol"},{"key":"41_CR66","first-page":"1","volume":"11","author":"C Zip","year":"2006","unstructured":"Zip C. A practical guide to dermatological drug use in pregnancy. Skin Ther Lett. 2006;11:1\u20134.","journal-title":"Skin Ther Lett"},{"issue":"11","key":"41_CR67","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/archpediatrics.2009.188","volume":"163","author":"KS Crider","year":"2009","unstructured":"Crider KS, Cleves MA, Reefhuis J, et al. Antibacterial medication use during pregnancy and risk of birth defects. Arch Pediatr Adolesc Med. 2009;163(11):978\u201385.","journal-title":"Arch Pediatr Adolesc Med"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-013-0041-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-013-0041-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-013-0041-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T17:49:22Z","timestamp":1563817762000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-013-0041-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,31]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["41"],"URL":"https:\/\/doi.org\/10.1007\/s40257-013-0041-9","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,31]]}}}